Under 36? Boost your career and apply for an ESC grant to conduct specialised or further cardiovascular research in a European centre of excellence.
National health systems in the EU face common challenges: increasing cost of healthcare, ageing populations associated with a rise of chronic diseases – leading to growing demand for healthcare –, shortages and uneven distribution of health professionals, health inequalities and inequities in access to health services. Moreover, the economic crisis limited the financial resources available.
Therefore, health systems need to be effective, accessible and resilient and must adapt effectively to tackle these significant challenges. Innovative health solutions and investment are key to this process.
The European Commission makes direct financial contributions in the form of grants in support of projects or organisations which further the interests of the EU or contribute to the implementation of an EU programme or policy. Interested parties can apply by responding to calls for proposals.
There are mainly two funding mechanisms: grants and tenders.
Find more information here:
Between 2014 and 2020, the EU will provide almost €80bn in funding for research, mainly through its flagship research programme Horizon 2020. Horizon 2020 is the biggest ever EU research and innovation programme and places more emphasis than ever on making sure that Europe’s promising ideas get from the laboratory to the market.Horizon 2020 will provide resources to encourage innovative small firms, fund more blue-sky research, and bring together different fields of science and technology. In doing so, Horizon 2020 aims to solve some of society’s biggest challenges, from ageing populations to the need for clean energy, and keep Europe’s economy competitive over the long term.
MORE about horizon 2020 HERE
The European Commission has launched a public stakeholder consultation which will feed into the interim evaluation of Horizon 2020. This interim evaluation will help improve the functioning of Horizon 2020, and will also be an important element in preparations of a next EU research and innovation programme.
Access the PDF version of the online questionnaire which will help you prepare your answers.
An additional funding instrument is the ‘’third EU Health Programme 2014-2020’’.The Health Programme is about fostering health in Europe by encouraging cooperation between Member States to improve the health policies that benefit their citizens. The programme aims to support and complement Member States health initiatives
More information here
The Innovative Medicines Initiative (IMI) is Europe's largest public-private initiative aiming to speed up the development of better and safer medicines for patients.
IMI supports collaborative research projects and builds networks of industrial and academic experts in order to boost pharmaceutical innovation in Europe.
IMI is a joint undertaking between the European Union and the pharmaceutical industry association EFPIA.
More about IMI here
Health project promoters, both from the public and the private sector, can benefit from the Investment Plan by getting financing from the European Fund for Strategic Investments (EFSI), registering a project to reach potential investors worldwide through the European Investment Project Portal (EIPP), and making use of the advisory services of the European Investment Advisory Hub (EIAH).
EFSI will support investment projects mostly in the following areas, recognising the importance of infrastructure investments but also the role of innovation in health systems, research and medical education:
Learn more about EFSI
Want to know more about how to apply for EU funding and get insights into how EU projects are managed? Attend the special ESC/EU joint session at ESC Congress 2016: European cardiovascular research and innovation – EU funding and networking opportunities. 29 August from 14:00 - 15:30 in Da Vinci, The Hub
Our mission: To reduce the burden of cardiovascular disease
© 2017 European Society of Cardiology. All rights reserved